Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer

NCT06483425 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06483425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06483425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
March 1, 2024
Completion date
December 1, 2028
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker, ovarian cancer